文献速递组学、生物样本库与精准医学流行病学与生物统计

代谢组学数据可补充流行病学数据库中的药物使用信息:潜在肾脏捐献者的初步研究

Metabolomics data complemented drug use information in epidemiological databases: pilot study of potential kidney donors.
PubMed 文献 · J Clin Epidemiol · 2021-02-09

该初步研究对移植队列中100名随机选择的对照者(女性占50%)的尿液进行液相色谱-质谱代谢组学分析,通过谱库搜索和靶向信号提取鉴定药物。在83名有药物使用信息的受试者中,鉴定出22种预期和26种非预期处方药,另有28种预期处方药未被检出。结论认为代谢组学数据可为许多药物提供分子证据,有助于补充和强化流行病学数据库。

要点

  • 尿液中可检出多种处方药和非处方药的分子证据。
  • 代谢组学鉴定结果与临床数据库记录存在较大差异。
  • 代谢组学有望补充和强化流行病学药物暴露信息。

核心结论

  • 液相色谱-质谱代谢组学数据可为许多药物提供分子证据,有助于补充和强化流行病学数据库。

研究设计与样本

  • 对移植队列中100名随机选择的对照者(女性占50%)进行尿液液相色谱-质谱代谢组学分析。
  • 通过谱库搜索和靶向信号提取鉴定药物。

主要发现

  • 在83名有药物使用信息的受试者中,鉴定出22种预期处方药和26种非预期处方药,另有28种预期处方药未被检出。
  • 在17名无药物使用信息的受试者中鉴定出7种处方药,并在全部100名受试者中鉴定出58种非处方药。

临床怎么用

  • 代谢组学检测可作为流行病学研究中药物暴露信息的补充手段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to investigate whether clinical metabolomics, which is increasingly applied in population-based and epidemiological studies, can be used to provide analytical evidence of exposures, and whether such information can be useful to strengthen and/or complement corresponding clinical database entries, taking drug use as an example. STUDY DESIGN AND SETTING: Liquid chromatography-mass spectrometry (LC-MS) metabolomics analyses were performed on urine from 100 randomly-selected control subjects (50% females) from the TransplantLines Food and Nutrition Biobank and Cohort Study (NCT identifier 'NCT02811835'), and drugs were identified through spectral library searching and targeted signal extraction. RESULTS: In 83 subjects for whom drug use information was available, 22 expected and 26 unexpected prescription-only drugs were identified, while 28 expected prescription-only drugs remained undetected. In addition, 7 prescription-only drugs were found in 17 subjects for whom drug use information was unavailable, and 58 over-the-counter drugs were identified in all 100 subjects. CONCLUSION: Molecular evidence for many drugs could be retrieved from LC-MS metabolomics data, which could be useful to complement and strengthen epidemiological databases given that considerable discrepancies were found between analytically-identified drugs and drugs listed in the available clinical database.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Klont F, Kremer D, Gomes Neto AW, et al. Metabolomics data complemented drug use information in epidemiological databases: pilot study of potential kidney donors. J Clin Epidemiol. 2021. PMID: 33577985. doi:10.1016/j.jclinepi.2021.02.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。